| 余金十,李茜,崔勇.基因组学和定量药理学用于化疗药物治疗肿瘤患者的个性化治疗研究进展[J].中国海洋药物,2024,43(6):73-82. |
| 基因组学和定量药理学用于化疗药物治疗肿瘤患者的个性化治疗研究进展 |
| Research Progress of Personalized Treatment for Cancer Patients with Chemotherapy Drugs Using Genomics and Quantitative Pharmacology |
| 投稿时间：2023-12-19 修订日期：2024-01-03 |
| DOI：10.13400/j.cnki.cjmd.2024.06.008 |
| 中文关键词: 基因组学 定量药理学 奥沙利铂 阿糖胞苷 |
| English Keywords:Genomics Quantitative Pharmacology Oxaliplatin Gemcitabine |
| Fund Project: |
|
| 摘要点击次数: 215 |
| 全文下载次数: 1 |
| 中文摘要: |
| 癌症是威胁公众健康的主要疾病，严重危害人类的生命健康安全，是全球主要死因之一。目前，使用化疗药物是丧失手术根治机会中晚期癌症患者的优选，但其治疗效果和不良副作用给治疗带来了巨大的挑战，对患者的生活质量造成严重影响。因此，化疗药物的个性化治疗在提高治疗效果和减少副作用等方面都具有重要意义。其中，基因组学和定量药理学等研究的个性化治疗已经开始打破传统医学的边界，成为精准医学研究的重要方向。本文综述了包括奥沙利铂以及海洋药物阿糖胞苷等在内的四种常见的化疗药物。 |
| English Summary: |
| Cancer is a major disease that threatens public health and seriously endangers human life and health security. It is one of the leading causes of death worldwide. Currently, the use of chemotherapy drugs is preferred for advanced cancer patients who have lost the opportunity for surgical cure. However, the treatment effects and adverse effects pose significant challenges to the treatment, severely impacting the quality of life of patients. Therefore, personalized treatment with chemotherapy drugs is important in improving treatment effectiveness and reducing side effects. Personalized treatments based on genomics and quantitative pharmacology have begun to break the boundaries of traditional medicine and have become an important direction in precision medicine research. This article reviews four common chemotherapy drugs, including oxaliplatin and the marine drug cytarabine. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |